In Brief: Okla. Plan B restriction blocked; CRN knocks disease claims via NAD; Facebook testimonial stings Vibrant Life
This article was originally published in The Tan Sheet
Executive Summary
Oklahoma judge blocks Plan B restrictions; CRN challenges disease claims via NAD; Lonza backs Alomune claims, ERSP says; Facebook testimonial prompts Vibrant Life warning; Rx adulterant recalls, alerts; and Codex adopts 11 nutrient reference values;.
You may also be interested in...
Firms Navigate Social Media Safely Following Loss Of Facebook Protection
Several drug companies may have shuttered their Facebook pages prematurely in August after the social networking site revoked their exclusive privilege to block consumer comments on their walls.
International Panel’s Nutrient Value Guideline May Boost Supplement Exports
Dietary supplement firms soon could export products internationally without having to reformulate to accommodate local nutrient value regulations.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.